Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Journal of Crohn'S & Colitis|September 30, 2017
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA StudyGeert D'Haens, Séverine Vermeire, Harald Vogelsang, et al.Gastroenterology|February 9, 2013
Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrierTobias Müller, Claudia Beutler, Almudena Hurtado Picó, et al.Journal of Medical Internet Research|February 25, 2026
The Alberta Risk of Bias Assessment Tool (AQAT:RoB) for the Evaluation of Medical Large Language Model Question-Answer Studies: Development and Pilot ValidationCarrie Ye, Joseph Ross Mitchell, Daniel C Baumgart, et al.Journal of Medical Internet Research|April 8, 2026
The Alberta Quality Assessment Tool: Risk of Bias (AQAT:RoB) for the Evaluation of Medical Large Language Model Question-Answer Studies: Development and Pilot ValidationCarrie Ye, Joseph Ross Mitchell, Daniel C Baumgart, et al.Gastroenterology|November 3, 2015
Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative ColitisGaik W Tew, Jason A Hackney, Deena Gibbons, et al.Alimentary Pharmacology & Therapeutics|November 7, 2019
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE studyAnnick Moens, C Janneke van der Woude, Mette Julsgaard, et al.Lancet (London, England)|May 13, 2014
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trialSéverine Vermeire, Sharon O'Byrne, Mary Keir, et al.Journal of Crohn'S & Colitis|April 16, 2013
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelinesJ Panes, Y Bouhnik, W Reinisch, et al.Inflammatory Bowel Diseases|May 23, 2018
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European StudyUri Kopylov, Bram Verstockt, Luc Biedermann, et al.The Journal of Experimental Medicine|July 30, 2008
Autoregulation of Th1-mediated inflammation by twist1Uwe Niesner, Inka Albrecht, Marko Janke, et al.Pageof 15